Vital expertise in virotherapy manufacturing
Specializing in live viruses and viral vectors─ we enable our customers in the development and manufacture of transformational oncolytic virus, gene therapy, and vaccine products to advance human health.
Since 2002, we have supported global clientele across clinical and regulatory arenas with comprehensive CDMO services
From starting material generation to full drug substance and product capabilities
Vibalogics can assist you through a comprehensive service portfolio – ensuring the success of your virotherapy, beginning with process development and technical transfer feasibility, through cGMP production and validation.
Cell & Virus Banking
Drug Substance & Drug Product
QC Release & Stability Testing
What makes us the best choice
A “Pure-Play” Virotherapy CDMO
20 years focused on delivering virotherapy services with over $200M in active investment.
Critical guidance and technical oversight enable our customers development of robust products and processes for clinical- and commercial-use.
Complete offerings from GMP cell & viral banking, process and analytical development, GMP drug substance and drug product fill & finish.
Capacity & Quality
BSL-2 facilities and continues reinvestment provide capacity-rich infrastructure with quality compliance to international GMP standards.
GMP Manufacturing of Oncolytic Viruses: Critical Steps and Key Considerations
In our latest edition of Virotherapy Insider: Deep Dive, we will discuss the critical steps involved in OV development, manufacturing, testing, and explore the measures that need to be taken at each stage to ensure success.